Trial Profile
Effects of telmisartan versus aliskiren on glucose and insulin metabolism and left ventricular mass in obese elderly patients with hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 May 2012
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Telmisartan (Primary)
- Indications Hypertension
- Focus Pharmacodynamics
- 22 May 2012 Results presented at the 27th Annual Scientific Meeting of the American Society of Hypertension.
- 14 May 2012 New trial record
- 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.